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Summary
Laparoscopy has improved surgical treatment of various diseases
due to its limited surgical trauma and has developed as an inte-
resting therapeutic alternative for the resection of colorectal cancer.
Despite numerous clinical advantages (faster recovery, less pain,
fewer wound and systemic complications, faster return to work) the
laparoscopic approach to colorectal cancer therapy has also resul-
ted in unusual complications, i.e. ureteral and bladder injury which
are rarely observed with open laparotomy. Moreover, pneumothor-
ax, cardiac arrhythmia, impaired venous return, venous thrombosis
as well as peripheral nerve injury have been associated with the in-
creased intraabdominal pressure as well as patient’s positioning du-
ring surgery. Furthermore, undetected small bowel injury caused
by the grasping or cauterizing instruments may occur with laparos-
copic surgery. In contrast to procedures performed for nonmalig-
nant conditions, the benefits of laparoscopic resection of colorectal
cancer must be weighed against the potential for poorer long-term
outcomes of cancer patients that still has not been completely ruled
out. In laparoscopic colorectal cancer surgery, several important
cancer control issues still are being evaluated, i.e. the extent of
lymph node dissection, tumor implantation at port sites, adequacy
of intraperitoneal staging as well as the distance between tumor
site and resection margins. For the time being it can be assumed
that there is no significant difference in lymph node harvest be-
tween laparoscopic and open colorectal cancer surgery if oncologi-
cal principles of resection are followed. As far as the issue of port
site recurrence is concerned, it appears to be less prevalent than
first thought (range 0–2.5%), and the incidence apparently corre-
sponds with wound recurrence rates observed after open proce-
dures. Short-term (3–5 years) survival rates have been published by
a number of investigators, and survival rates after laparoscopic sur-
gery appears to compare well with data collected after conventional
surgery for colorectal cancer. However, long-term results of pros-
pective randomized trials are not available. The data published so
far indicate that the oncological results of laparoscopic surgery
compare well with the results of the conventional open approach.
Nonetheless, the limited information available from prospective
studies leads us to propose that minimally invasive surgery for co-
lorectal cancer surgery should only be performed within prospec-
tive trials. 
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Zusammenfassung
Durch das reduzierte Zugangstrauma der laparoskopischen Opera-
tionsverfahren hat sich die Therapie einer Vielzahl von Erkrankun-
gen verändert und diese Methode ist so auch zu einer interessanten
therapeutischen Alternative beim kolorektalen Karzinom geworden.
Trotz einer Vielzahl von klinischen Vorteilen (kürzere Rekonvale-
szenz, geringere postoperative Schmerzen, weniger systemische
und lokale Komplikationen, schnellere Wiedererlangung der Ar-
beitsfähigkeit), ist es durch den laparoskopischen Zugang auch zu
einer Zunahme von bislang ungewohnten Komplikationen (z.B. Bla-
sen- und Uretherverletzungen) gekommen. Weiterhin wurde eine
höhere Inzidenz von Pneumothoraces, Herzrhythmusstörungen, Ve-
nenthrombosen und peripheren Nervenverletzungen aufgrund des
perioperativ erhöhten intraabdominellen Drucks beobachtet. Darü-
ber hinaus besteht die Gefahr von unbemerkten Dünndarmverlet-
zungen, die intraoperativ durch Greif- bzw. Koagulationsinstrumen-
te verursacht werden können. Im Gegensatz zu Operationen, die
wegen gutartiger Erkrankungen durchgeführt werden, müssen die
Vorteile der laparoskopischen Chirurgie bei malignen Erkrankungen
gegen die potentiell schlechteren onkologischen Langzeitergeb-
nisse abgewogen werden, welche bislang noch nicht endgültig aus-
geschlossen werden konnten. Diesbezüglich gibt es wesentliche on-
kologische Kriterien, die sich bei der laparoskopischen Chirurgie
noch in der Evaluation befinden. Hierzu zählen unter anderem das
Ausmaß der Lymphknotendissektion, die Frage der Tumorzellim-
plantation im Bereich der Trokarinzisionen, die Qualität des intra-
operativen Tumor-Stagings sowie das Ausmaß der Sicherheitsab-
stände. Die bislang vorliegenden Ergebnisse deuten darauf hin,
dass keine signifikanten Unterschiede zwischen konventioneller
und laparoskopischer Chirurgie bezüglich dieser onkologischen Kri-
terien bestehen, wenn die allgemein gültigen Prinzipien der onkolo-
gischen Chirurgie befolgt werden. Insbesondere das Auftreten von
Trokarmetastasen (Inzidenz 0–2,5%) scheint nicht so häufig zu sein,
wie initial befürchtet, und entspricht der Rate von Metastasen im
Bereich der Laparotomienarbe nach konventioneller Operation. Die
Kurzzeit-Überlebensraten (3–5 Jahre), die von einigen Arbeitsgrup-
pen vorgelegt wurden, zeigen keine signifikanten Nachteile für Pa-
tienten nach laparoskopischer Chirurgie gegenüber konventionell
operierten Patienten. Langzeit-Ergebnisse von prospektiv randomi-
sierten Studien liegen allerdings noch nicht vor. Die bislang verfüg-
baren Daten deuten darauf hin, dass die onkologischen Ergebnisse
der laparoskopischen Chirurgie beim kolorektalen Karzinom mit
den Ergebnissen der konventionellen Chirurgie vergleichbar sind.
Aufgrund der bislang unzureichenden Datenlage aus prospektiv
randomisierten Studien halten wir den Einsatz der minimal invasi-
ven Chirurgie beim kolorektalen Karzinom nur im Rahmen von pro-
spektiven Studien für gerechtfertigt. 
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Introduction
Laparoscopy has improved surgical treatment of various dis-
eases due to its limited surgical trauma [1]. During recent
years the laparoscopic approach therefore has developed as
an interesting therapeutic alternative for the resection of col-
orectal cancer. This procedure has been shown to be feasible
in most patients with benign disease and can be performed
without an increase of perioperative morbidity and mortality
rates [2–5]. The laparoscopic approach usually allows for a
rapid return to preoperative activity levels with significantly
shorter hospitalization, and a recent report indicates reduced
rates of postoperative ileus, wound infection and cardiorespi-
ratory complications after laparoscopic surgery when com-
pared with the open approach [6].
Experimental and clinical data suggest that laparoscopic
surgery is also suitable for the treatment of malignant disease,
and it appears that laparoscopic resection of colorectal cancer
is associated with clinically relevant benefits during the first
weeks after surgery and that it can be performed with the
same intention of radical treatment as conventional resection
[7]. A recent study, however, reported that only minimal
short-term quality of life benefits could be observed with la-
paroscopically assisted colectomy when compared with open
colectomy for colon cancer [8]. These authors therefore con-
cluded that laparoscopic colectomy should only be performed
within prospective trials to evaluate the oncological safety of
this surgical approach [8] as it has also been suggested by the
American Society of Colon and Rectal Surgeons [9]. The data
published so far, nonetheless, indicate that the oncological re-
sults of laparoscopic surgery compare well with the results of
the conventional open approach [10–15]. Until now, the avail-
able trials assessing the value of laparoscopy in colorectal can-
cer, however, lacked sufficient statistical power due to small
numbers of patients or had short follow-up periods which did
not allow proper evaluation of the oncological safety [1]. Thus,
despite the observed clinical advances of the minor access ap-
proach, the role of minimal invasive procedures in oncological
surgery is not yet defined [16]. 
We discuss herein the established procedures of minimally in-
vasive surgery for colorectal disease as well as the current role
of laparoscopic surgery for colorectal carcinoma with special
attention to surgical safety (length of surgery, blood loss, peri-
operative morbidity, and mortality rates) as well as the onco-
logical results (number of harvested lymph nodes, length of
security margins, long-term survival). Furthermore, we ad-
dress the immunological effects of laparoscopic versus con-
ventional colorectal surgery.
Established Minimally Invasive Surgical Procedures for
Colorectal Disease
In 1997, Herold et al. [17] reported that only 15% of all surgi-
cal departments in Germany had experience with laparoscop-
ic colorectal operations. Furthermore, these authors showed
that only 1% of all cases (n = 143,000) underwent laparoscop-
ic surgery [17] which has also been reported by Köckerling et
al. [5]. Even though no recent study addresses the interesting
clinical question of how many laparoscopic colorectal proce-
dures are being performed when compared with the total
number of cases undergoing surgery for colorectal diseases, it
appears that minimal invasive colorectal surgery is gaining
more and more attention and is being performed in a number
of surgical departments.
The current role of laparoscopic surgery in colorectal cancer
can be divided into three categories: diagnosis and staging,
palliation and diversion as well as curative resection [18]. Tit-
tel and Schumpelick [19] showed that the most frequently per-
formed laparoscopic colorectal procedures are resections of
the sigmoid colon (30%), anterior rectal resections (31%) as
well as resections of the ascending colon (20%). The study by
Köckerling et al. [5], however, revealed that laparoscopic pro-
cedures are more common on the left colon and rectum than
on the right colon. In our institution the minimal invasive ap-
proach was most commonly used for the rectum (70%) and
the majority of these interventions were anterior resections
(54%) for benign as well as malignant diseases. 
Laparoscopic surgery of the transverse colon is technically de-
manding due to the position of the greater omentum and can
be impossible due to anatomical problems (e.g. elongation of
the transverse colon). Only limited experience with laparo-
scopic surgery on the descending colon (3.5%) has been re-
ported in the literature [19]. This is surprising since mobiliza-
tion of the left colon is necessary for a tension-free anastomo-
sis after anterior rectal resections and, therefore, is feasible in
the clinical setting. 
As far as the technique of total mesorectal excision (TME)
for low rectal cancer is concerned, it has been shown by Weis-
er and Milsom [20] in a human cadaver model as well as in a
clinical study that TME can be performed via the minimally
invasive approach. This observation has been recently con-
firmed by Hartley et al. [21]. In our institution, laparoscopic
TME is routinely performed in patients suffering from rectal
cancer. It appears that the surgical site as well as the resection
planes are easier to evaluate and to dissect by the laparoscop-
ic approach than via conventional open surgery. This clinical
experience, however, still lacks support by results from
prospective clinical studies. 
Surgical Safety
Advances in the development of laparoscopic instruments
allow for the safe resection of polyps or malignant disease.
Until now, T1, T2 and T3 lesions can be resected using the la-
paroscopic approach while T4 tumors require conversion to
open laparotomy for en bloc resection of the affected organs
[13]. 
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The laparoscopic approach to colorectal cancer therapy has
resulted in unusual complications, i.e. ureteral and bladder in-
jury which are rarely observed with open laparotomy [13].
Larach and Gallagher [22] recently reviewed possible compli-
cations of laparoscopic surgery for rectal cancer. According to
these authors, gas embolism appears to be a rare complication
which is usually associated with the placement of a Veress
needle directly into a vein [22]. As opposed to Larach and
Gallagher [22] who recommend not to use the Veress needle
for installation of the pneumoperitoneum, Hüttl et al. [23]
showed that most surgeons in Germany (70%) still apply this
method for placement of the initial port. In addition to the
above-mentioned perioperative complications, pneumotho-
rax, cardiac arrhythmia, impaired venous return, venous
thrombosis as well as peripheral nerve injury have been asso-
ciated with the increased intraabdominal pressure as well as
patient’s positioning during surgery [22]. Furthermore, unde-
tected small bowel injury caused by the grasping or cauteriz-
ing instruments may occur more often with laparoscopic
surgery (range 0.2–5%) than during conventional open proce-
dures [13, 22]. Uncontrolled bleeding and major hemorrhage
during laparoscopic surgery result from blunt dissection or in-
correct clip and stapler placement. These complications re-
quire rapid conversion to open laparotomy if the anatomy be-
comes unclear or the bleeding source cannot be controlled
[22]. 
According to Köckerling et al. [5], laparoscopic colorectal
procedures can be performed with a postoperative mortality
rate of less than 2% in a selected patient group. The overall
morbidity rate in the study by Köckerling and colleagues was
21%, and the clinical anastomotic leakage rate was 5% [5].
A recent randomized trial compares the short-term quality-
of-life outcomes after laparoscopically assisted colectomy with
those of open colectomy for colon cancer in 428 patients [8].
The authors reported a statistically significant but clinically
modest decrease in the duration of postoperative inhospital
analgesia and in length of stay (0.8 days) for patients after la-
paroscopic resection [8]. These differences, however, did not
translate into statistically significant improvements in symp-
toms or quality of life during the immediate postoperative or
the 2-month follow-up period [8]. 
In our institution, mean length of laparoscopic colorectal
surgery was 229 ± 13 min, and the mean intraoperative blood
loss was 290 ± 36 ml, requiring blood transfusion in 6% of our
patients. Perioperative mortality and morbidity rates were 0
and 31%, respectively. A revision due to postoperative com-
plications became necessary in 11% of our patients.
Oncological Safety
When performing laparoscopic colorectal cancer surgery,
there are important cancer control issues to be checked. These
include the extent of lymph node dissection, tumor implanta-
tion at port sites, adequacy of intraperitoneal staging as well as
the distance between tumor site and resection margins. 
Although a number of studies have shown that the extent of
laparoscopic curative resection of bowel and lymphatic tissue
is comparable to that with open surgery [10–14, 24, 25], la-
paroscopic surgery for the cure of colorectal cancer remains
controversial. In contrast to procedures performed for non-
malignant conditions, the benefits of laparoscopic resection of
colorectal cancer must be weighed against the potential for
poorer long-term outcomes of cancer patients that still has not
been completely ruled out. Poorer long-term results may be
due to inadequate resections, port site recurrences, or unusual
spread of metastases after laparoscopic surgery for malignant
disease [8].
The identification of the tumor site as well as possible addi-
tional lesions may be difficult during laparoscopic colorectal
surgery. Preoperative colonoscopy therefore is mandatory to
avoid the missing of additional lesions which can be detected
in almost 5% of patients with colorectal cancer [26, 27].
The fear of port site recurrence is the leading concern for la-
paroscopic colorectal cancer resection. However, initial re-
ports of an incidence of trocar metastases as high as 20% ap-
pear to be attributable to the individual surgical technique
[28]. This phenomenon is less prevalent than first thought
(range 0–2.5%) and appears to correspond with wound recur-
rence rates observed after open procedures [1, 13]. Welch and
Donaldson [29], however, reported an incidence of almost
17% laparotomy recurrences identified at autopsy after open
resection of colorectal cancer. 
The study by Sugarbaker and Corlew [30] support the notion
that an extended regional lymph node dissection does not ap-
pear to improve survival when compared with a regional dis-
section. Despite this observation, it is our believe – which is
also supported by others [31a] – that significant prognostic in-
formation is based on resected lymph nodes [31b]. As far as
the published results of lymph node harvest are concerned,
Lin and Ota [13] recently showed that the mean number of re-
sected lymph nodes during laparoscopic colorectal cancer
surgery varied between 6 and 19 nodes per resected specimen
in 21 different studies published between 1993 and 2000. For
the time being it can be assumed that there is no significant
difference in lymph node harvest between laparoscopic and
open colorectal cancer surgery if oncological principles of re-
section are followed [13].
In our institution, a mean number of 14 ± 1 lymph nodes was
detected within the cancer-bearing specimen after laparoscop-
ic surgery while after open surgery 19 ± 1 lymph nodes (p <
0.05) were available for pathological evaluation. The clinical
relevance of this observation still remains to be determined.
Our findings, however, indicate that during laparoscopic
surgery for colorectal cancer the principles of oncological re-
sections must be followed with great care in order to harvest a
sufficient number of lymph nodes. The mean lengths of securi-
ty margins measured in the specimens resected in our depart-
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ment during laparoscopic surgery were 13 ± 1 cm orally and 4
± 1 cm distally. The circumferential resection margin has re-
cently become of special interest since Birbeck et al. [32] have
shown that infiltration of the circumferential margin or cancer
infiltration below 1 mm to the circumferential margin is an im-
mediate predictor of survival and serves as a useful indicator
of surgical quality. The circumferential resection margin after
minimally invasive surgery for colorectal cancer was 3 ± 1 cm
in our department. The observations from our department
support the notion that sufficient security margins can be
achieved with laparoscopic surgery for malignant disease. This
was also reported by other groups [10–14, 24, 25]. Until now,
only limited survival data are available in our institution. The
achieved 3-year survival rates, however, are comparable with
the survival rates of our patients after conventional open
surgery for colorectal cancer (fig. 1; log rank = 0.8112). Com-
parable short-term (3–5 years) survival rates were also report-
ed by Fleshman et al. [33], Schwandner et al. [14] as well as
Leung et al. [34]. Long-term results of prospective random-
ized trials are not available despite these promising findings.
Immunological Effects
Minimizing surgical trauma due to a smaller access to the sur-
gical site might have beneficial effects on the postoperative
immune status of the individual patient. This could contribute
to fewer infectious complications, faster recovery as well as
better killing of circulating tumor cells in cancer patients. 
Despite numerous publications addressing this interesting
clinical issue, there is no scientific evidence-based answer to
the question of whether or not the above-mentioned hypothe-
sis on the advantages of minimal access surgery holds true.
Nonetheless, the degree of postoperative inflammation seems
to be lower after laparoscopic surgery [16]. Furthermore,
there is no doubt that far less impairment of lung function oc-
curs after minimal invasive surgery [16]. Moreover, less post-
operative pain, shorter duration of hospitalization, and faster
recovery have been observed after laparoscopic colorectal
cancer surgery when compared with the conventional ap-
proach [16, 35]. The observed advantages in quality of life
however level out in the course of time [8]. Until now, only
few prospective clinical studies were published that compare
the immunological response to laparoscopic with that to con-
ventional surgery for colorectal cancer. Nonetheless, IL-6 and
C-reactive protein levels were reported to be lower after la-
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Fig. 1. Three-year survival rates after open surgery for rectal cancer
(+; n = 477 patients) and after laparoscopic rectal cancer resection
(…+…; n = 65 patients). log rank = 0.8112.
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Fig. 2. Serum interleukin-6 levels as determined by ELISA (Biosource,
Camarillo, CA, USA) in patients after laparoscopic (lap.; n = 20) and con-
ventional (conv.; n = 20) colorectal surgery (surg.).
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Fig. 3. Circulating natural killer cells [CD3–, CD16/56+] as determined
by flow cytometry (FACScan, Becton Dickinson, Heidelberg, Germany)
in patients after laparoscopic (n = 20) and conventional (n = 20) colorectal
surgery.
paroscopic rectosigmoid resections [16]. This observation was
also confirmed in a recent pilot study in our institution. After
laparoscopic colorectal surgery, we observed a significantly
smaller peak of serum IL-6 levels (fig. 2). Schwenk et al. [36]
also observed significantly lower IL-6 and CRP plasma levels
after laparoscopic than after conventional colorectal resec-
tions while IL-1RA and IL-10 levels showed no significant dif-
ferences between both study groups. Moreover, the evaluation
of the immune status after laparoscopic and conventional col-
orectal surgery by flow cytometry revealed significantly higher
numbers of circulating natural killer cells in patients after min-
imal invasive colorectal resection (fig. 3). Other groups also
observed significantly better preservation of lymphocyte sub-
populations, neutrophil function as well as cell-mediated im-
munity after laparoscopic versus open colorectal surgery
[37–39]. The data published so far support the notion that la-
paroscopic colorectal surgery may not be as detrimental for
the postoperative immune status of patients undergoing col-
orectal cancer surgery. Prospective randomized immunologi-
cal studies, however, are not available to evaluate whether or
not these findings are of clinical and oncological relevance.
The immunological role of minimally invasive surgery in on-
cological surgery therefore is not completely determined.
Discussion
The first report on laparoscopic colorectal interventions was
published by Jacobs et al. [40] in 1991. Since then a rapid
progress has been made in this field of minimally invasive
surgery. Colorectal resections, nonetheless, still are among the
most challenging current applications of laparoscopic surgery,
and the demand on surgeons to acquire these advanced skills
is increasing [41].
Optimal patient care and treatment-regimens for colorectal
cancer patients remain controversial, and despite major ef-
forts the 5-year-survival rate may be as low as 50% [42, 43]. In
order to improve these unfortunate survival rates, different
protocols of preoperative radiochemotherapy as well as surgi-
cal procedures have been introduced [44, 45]. Among the sur-
gical procedures laparoscopy has become an interesting thera-
peutic alternative for the resection of colorectal cancer. Until
now, laparoscopic colorectal surgery has been performed
without an increase of perioperative morbidity and mortality
rates [2, 3]. After laparoscopic surgery a rapid return to pre-
operative activity levels with significantly shorter hospitaliza-
tion has been observed, and reduced rates of postoperative
ileus, wound infection and cardiorespiratory complications
were reported [6]. Nonetheless, a recent report by Weeks et al.
[46] indicated only minor advantages for patients undergoing
laparoscopic colon cancer surgery. These authors concluded
that laparoscopic surgery should not be offered to colon can-
cer patients until ongoing trials establish that laparoscopy is as
effective as open surgery in preventing recurrence and death
from colon cancer [46]. Additional studies, however, indicated
that the oncologic results of laparoscopic surgery compare
well with the results of the conventional open approach
[10–12]. 
Laparoscopic colorectal cancer resection is feasible, but in
view of the ongoing discussion about the oncological safety of
this approach [10–12, 46], it should only be performed within
clinical studies and in surgical centers that have sufficient ex-
perience with laparoscopic colorectal surgery for benign dis-
eases. 
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